Case report: diversifying cataract outcomes
Many options with one single Nd:YAG laser
AI ocular screenings facilitate early intervention for paediatric patients
Enhanced detection and diagnosis of common and severe diseases
How biosimilars expand treatment options for patients with retinal disease
An in-depth case study conversation
What do you do when there is no cataract?
Standalone, minimally-invasive glaucoma treatments
Plan your day: afternoon sessions at the Angiogenesis, Exudation, and Degeneration 2024 Conference
The afternoon sessions begin after lunch and continue well into the evening at the Angiogenesis, Exudation, and Degeneration 2024 meeting
Angiogenesis, Exudation and Degeneration Conference: A 1-day virtual symposium of all things retina
The one-day event will be held online Saturday, February 3, 2024, and is sponsored by the Bascom Palmer Eye Institute, University of Miami Health System
Iridex and Imperial College Healthcare NHS Trust announce collaborative MicroPulse TLT study
The partnership establishes a large-scale enrollment platform for research on MicroPulseTransscleral Laser Therapy (TLT)
Corneas harvested from patients who died of drowning are viable for transplantation
Postoperative outcomes of the tissues obtained from these donors were satisfactory
Intra-anterior chamber anti-VEGF injections feasible treatment for advanced paediatric vitreoretinal diseases
Investigators advised that further studies should be conducted to understand more precisely the benefits and risks
NEI shares outcomes from workshop on cerebral/cortical visual impairment
Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry
Disease management and data integration: Zeiss Meditec looks ahead following Dutch Ophthalmic Research Center announcement
Euan Thomson, Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit at Carl Zeiss Meditec, discusses plans for the company's vitreoretinal surgery workflows following announcement of DORC acquisition
Morrow and Novacel Optical partner ahead of eProgressive smart glasses distribution
A strategic distribution partnership is expected to make Morrow’s eProgressive smart glasses available to consumers in the second quarter of 2024
Rayner announces acquisition of Swiss Ophthalmology Innovation and Sophi phaco technology
The UK-based Rayner announced the acquisition will enhance its portfolio in the cataract surgery space
AAO welcomes 128th president, Jane C. Edmond, MD, to 2024 term
Dr Edmond has also served as president of the American Association for Paediatric Ophthalmology and Strabismus and an oral examiner for the American Board of Ophthalmology
Annexon outlines ANX007 global pivotal programme for geographic atrophy, beginning mid-2024
The trial will use vision preservation as a primary outcome measure, according to Annexon
Technology company Gentex announces acquisition of ocular device developer eSight
eSight, a wearable assistive technology company, produces comprehensive equipment for patients with over 20 ocular disorders
UK ophthalmology students report impact of COVID-19 on clinical education
A reduction in clinical exposure has harmed student confidence, according to a questionnaire administered in the United Kingdom
European Commission grants EU marketing authorisation for aflibercept (Eylea) 8 mg
The European Union approval applies to aflibercept 8 mg for treatment of nAMD and DME
Prevent Blindness marks Glaucoma Awareness Month with free educational resources, glaucoma toolkit
Prevent Blindness will offer downloadable fact sheets, shareable social media graphics and educational videos for patients
The year in eye care: 5 top stories from Modern Retina in 2023
Catch up on Modern Retina's top stories, and ones you may have missed in 2023
The year in eye care: Ophthalmology Times presents its 2023 Wrapped
A look back at some of the biggest stories in 2023, from our US partners at Ophthalmology Times
The year in eye care: Top 5 optometry stories from 2023
From FDA approvals to innovations in lens tech, 2023 was a big year in eye care
Looking back, looking forward: top stories from Ophthalmology Times Europe 2023
A review of our most important content from throughout the year
Faricimab for nAMD and DME: Welcome to the real world
Real-world data from using faricimab to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME)
The case for ultrawidefield-guided swept-source OCT
The technology provides effective, efficient evaluations when paired with the right patients
New MIGS devices aid patients and test patience
In 2024, the waiting game will pay off for glaucoma specialists who are eager to develop fluency and implement new devices into their practices
Cannabis use carries no risk of primary open-angle glaucoma
Analysis suggested no evidence for a causal association of lifetime cannabis use and cannabis use disorder with primary open-angle glaucoma
Cross-linking in paediatric patients: The case for treating keratoconus without waiting for disease progression
The case for treating keratoconus without waiting for disease progression
Next-gen lasers and IOLs for every patient: the year ahead in cornea
Why “acceleration” is the industry keyword for 2024
Exonate’s lead ophthalmology candidate EXN407 meets endpoints in Phase Ib/IIa trial for diabetic macular oedema
EXN407 has the potential to be the first topical treatment for diabetic retinopathy and diabetic macular oedema
